Loading data
CRINYSE
| Unit: USD | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 2.9 bn USD | 2.84 bn USD | 2.95 bn USD | 3.21 bn USD | 3.49 bn USD |
| Gross profit | 1.31 bn USD | 1.37 bn USD | 1.4 bn USD | 1.47 bn USD | 1.66 bn USD |
| Selling, general and administrative expense | 1.19 bn USD | 1.1 bn USD | 1.09 bn USD | 1.11 bn USD | 1.19 bn USD |
| Operating profit | 143.93 m USD | 254.73 m USD | 323.41 m USD | 379.17 m USD | 497.08 m USD |
| Interest expense | 34.23 m USD | 31.33 m USD | 33.97 m USD | 42.78 m USD | 60.29 m USD |
| Profit before tax | 113.83 m USD | 230.81 m USD | 302.24 m USD | 316.74 m USD | 438.29 m USD |
| Income tax expense | 22.04 m USD | 45.3 m USD | 69.74 m USD | 66.7 m USD | 98.54 m USD |
| Net income (reported basis) | 91.8 m USD | 185.51 m USD | 232.5 m USD | 250.04 m USD | 339.75 m USD |
| Net income attributable to common shareholders | 89.49 m USD | 181.83 m USD | 228.22 m USD | 246.32 m USD | 335.64 m USD |
| Basic earnings per share | 2.53 USD/share | 5.12 USD/share | 6.24 USD/share | 6.34 USD/share | 7.83 USD/share |
| Diluted earnings per share | 2.53 USD/share | 5.12 USD/share | 6.24 USD/share | 6.34 USD/share | 7.81 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.